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The Sudden Hearing Loss (SHL) is a symptom caused by
more than 60 different diseases, including Vestibular
Schwannoma (VS). Shaia & Sheehy (1976) presented a study
with 1,220 cases of SHL reporting 1% incidence of VS. There
is no specific characteristic for the diagnosis of VS and
Magnetic Resonance Imaging (MRI) is the gold standard exam
to diagnose such disease. Aim: To determine the real
incidence of VS presenting as SHL performing MRI in all
patients with SHL. Study design: Transversal cohort.
Material and Method: Prospective study in which MRI
with gadolinium was performed in all patients with SHL in
the Emergency Service of Sao Paulo Hospital from April
2001 through May 2003. Results: MRI was performed in
49 patients with symptoms of SHL, with three cases (6.1%)
of VS found. Conclusion: The real incidence of VS
presenting as SHL may be greater than that mentioned in
conventional reports probably because MRI had not been
performed in all patients with SHL.
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INTRODUCTION
Sudden hearing loss (SHL) should be considered a
symptom and not a clinical entity since it could be caused
by more than 60 different diseases. It is a dramatic symptom
both for the patient and doctor providing health care and,
regardless of all new developments of diagnostic methods,
it is still quite challenging to confirm its etiology and
therapeutic possibilities.
Incidence of sudden hearing loss (SHL) is five (5) out
of forty-seven (47) in one thousand patients per year in
USA, with incidence increasing with age1. In Brazil the
reported frequency is 9 cases out of 10,000 urgent care
cases2. The mean age of affection ranges from 40 to 44
years. 1
Vestibular Schwannoma (VS) is among several causes
of Sudden Hearing Loss (SHL). The incidence of SHL ranges
from 3 to 26%3,4 in Vestibular Schwannoma patients. This
high variation could be related to the fact that such incidence
will be higher if the patient is asked about previous episode
of sudden deafness, since there is discrepancy between
symptom awareness by the patient and confirmation of
clinical symptom, mainly regarding the function of 8th cranial
pair5.
If we analyze it through a different perspective or,
considering patients with SHL, VS is reported as a cause in
1% of the cases2-4,6,7. The major challenge is to find out,
among such patients, which one of them resulted from VS,
since there are no clinical and pathognomic characteristics
able to easily guide us in to the diagnosis.
The objective of the present study was to evaluate
the real incidence of VS in our setting through MRI exams
performed in all patients with symptom of sudden hearing
loss in our service.
MATERIAL AND METHOD
Prospective study carried out at the Department of
ENT and Head and Neck Surgery and at the Department of
Imaging Diagnosis, Federal University of Sao Paulo, from
April 2001 to May 2003.
Patients with complaints of sudden hearing loss or
loss whose onset was within 72 hours underwent audiometry
and immittanciometry. We considered as diagnosis of sudden
hearing loss unilateral sensorineural hearing loss levels equal
or higher than 30 dB in at least three contiguous audiometric
frequencies. Individuals with hearing loss with different
characteristics than those above mentioned were excluded
from the study. The study included patients from both genders
with no age restriction.
Investigated patients underwent temporal bone and
brain MRI performed with Philips Gyroscan NT 1.5 tesla.
Images were acquired in T1 Turbo Spin Eco (TSE)
concentrated sequence in axial and coronal plans with and
without contrast and sections of 2.5 mm thick. T2 images
were also acquired in coronal plan in TSE with 2.5 mm
thickness and in 3D through 0.7 mm reconstruction. The
exam was complemented with cranial cross-sections in “Fluid
Attenuation Inversion Recovery” (FLAIR) in order to evaluate
the brain.
RESULTS
Sixty-one patients were included in the study. Twelve
out of those 61 discontinued the study or were not submitted
to MRI for different reasons. The age ranged from 15 to 91
years (mean age was 45.4 years), 23 (46.9%) were male
and 26 (53.1%) were female. In twenty-three patients
(46.9%) the involvement was on the left side and twenty-
six (53.1%) had it on the right side. Regarding ethnic group
34 (69.3%) of the patients were Caucasian, 10 (20.4%) were
Native Brazilian pardos, 2 (4.1%) were African-descendents,
and 3 (6.1%) were Asian-descendents.
Three out of forty-nine of the patients submitted to
MRI (6.1%) had VS, and 2 of them (4%) had intracanalicular
affection.
Case 1
NCS, 43 years old, Female, Caucasian. Patient
mentioned left ear sudden hearing loss for one day, associated
with tinnitus, dizziness and ear fullness. Symptoms were
related to an infectious event of the upper airways. Patient
had systemic arterial hypertension and hypercholesterolemia
under control and with normal physical evaluation. Input
audiometry presented thresholds of 60 dB in1 kHz, 50 dB
in 1.5 kHz and 45 dB in 2 kHz, the remaining frequencies
were normal. Laboratory tests were also normal. Patient
underwent MRI that evidenced of 8th nerve intrameatal
enhancement. Initial treatment was 60 mg/day prednisone
and 400 mg penthoxyphiline every 8 hours. Patient
presented full recovery after the 4th day of treatment with
normal audiometric results. Patient had a second episode of
left ear sudden hearing loss after 8 months with clinical and
audiometric results practically equal to those of the first crisis.
Medication was introduced again as previously prescribed
with full recovery and normal audiometry occurring after
thirty-five days of treatment. Patient was submitted to surgery
for removal of the VS, which measured approximately 8
mm, originating from the Superior Vestibular Nerve. Patient
evolved to profound hearing loss in high sounds (but with
92% discrimination) and no peripheral facial palsy.
Case 2
JAJ, 55 years old, Male, Caucasian. Patient with history
of left ear sudden hearing loss for two days, followed by
tinnitus. He had high blood pressure under control with
captopril and his physical examination was normal.
Audiometry showed 60 dB threshold in 1 kHz and 40 dB in
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1.5 kHz. MRI was performed and left-side intracanalicular
Vestibular Schwannoma was found. Patient had subtle
improvement with clinical treatment and refused to undergo
surgery, remaining under follow-up.
Case 3
NOS, 42 years old, Male, Brazilian Native. Patient
complaint of right-ear sudden hearing loss for fifteen days
followed by tinnitus, dizziness, ear fullness and headache.
History of previous diabetes mellitus. His audiometry showed
thresholds of 45 dB in 2 kHz, 70 dB in 3 kHz, 4 kHz, 6 kHz
and 8 kHz. MRI showed tumor of approximately 30mm at
the cerebellopontine angle. Patient underwent surgery to
remove the tumor and evolved to hearing loss and grade II
peripheral facial palsy on the right.
DISCUSSION
Vestibular Schwannoma is a benign tumor, which can
present itself in several ways from asymptomatic to dramatic
neurological symptoms. The overwhelming majority of VS
present auditory (95%) and vestibular (61%) symptoms,
which may also include trigeminal (9%) and facial (6%)5
nerves. SHL can be an initial symptom of VS in a variable
percentage of cases. Higgs (1973) reported 10% of VS ca-
ses with symptoms of sudden hearing loss as its first
manifestation, Morrison (1975) reported 17%, Hirsch &
Anderson (1980), 7.3%, Pensac et al. (1985), 14.5%, Berg
(1986), 13%, Thomsen & Tos (1988), 7%, Harder (1988),
5%, Odkvist (1988), 4%, Ogawa (1991), 22%, and Moffat
(1994), 10.2% (3). Berrentini (1997) mentioned a variation
ranging from 3 to 26% in the literature regarding cases of VS
with sudden hearing loss, and explained it as the result of
questions asked or not to patients about previous hearing
loss events 4. Another factor that also collaborated to this
large variation in results was that many times patients did
not notice the onset of the symptoms or the severity of the
auditory symptom, with major discrepancy between auditory
feeling and audiometry results5. The same applies to facial
and trigeminal function 5.
The etymological mechanisms of Sudden Hearing Loss
and VS have not been completely explained yet. Berenholz
(1992) explained that SHL occurs in VS due to tumor
compression of the 8th nerve1. The vestibule-cochlear nerve
has a transition zone in myelinization known as Obersteiner-
Redlich zone. This is a region with variable length in which
the myelin sheath of Schwann cells meets with
olygodendrocytes. The transition zone of the vascular
component is also located there. Peripheral vascular supply
occurs longitudinally, whereas the glial segment does not
have a regular standard, with few anastomoses. Therefore,
there is high potential for lesions in transition regions due to
low vascularization and myelinization 8. The compression of
this area could lead to reversible neuropathy through
blockage of nervous stimulus to the 8th nerve 1.
Yanagihara (1993) and Moffat (1994) mentioned tu-
mor compression of internal auditory artery (IAA), or even
intracanalicular intratumoral hemorrhage as a cause of Sudden
Hearing Loss in patients with VS ,9,10. According to Berrentini
(1997), however, if this hypotheses were true, cochlear and
vestibular dysfunction could be expected, since blood supply
to this systems is a common one4,; however, SHL is rarely
associated with acute vestibular dysfunction 11. Inoue (2000)
did not support the hypothesis of vascular compression
leading to SHL in VS, since vascular occlusion would be
associated with permanent cochlear loss, and ischemia of
basal and middle gyrus of the cochlea should affect the apical
gyrus, since vascularization of the apical gyrus comes from
the middle gyrus 7. The increased variability of audiometric
results of VS also does not comply with the standard of
vascular distribution of cochlea12. Ischemia, however, could
occur both in peripheral vessels and inside the stria vascularis
itself. Therefore, angiospasm and hemorrheological
phenomena inside vascular stria could lead to random and
reversible patterns of cochlear abnormalities. 7
Probably VS causes sudden hearing loss due to the
combination of such factors in different levels, which could
explain the variation of loss patterns, which range from
cochlear to retrocochlear 7.
The size of the tumor had already been related to
SHL, with higher frequency of SHL occurring in smaller
tumors9. Nevertheless if only the size was fundamental to
SHL pathogenic factors, all large tumors should have SHL
symptom even in smaller sizes. Most importantly than tu-
mor size is its location (in or out of the internal auditory
canal). Moffat (1994), in his case study carried out in 11
patients with SHL resulting from VS, reported that there was
no significant statistical difference regarding distribution per
size, however all SHL cases due to VS presented lateral
tumors, that is, inside the IAC. None of the medial tumors in
his case studies presented SHL. Three patients in our study
presented SHL resulting from VS, only one patient (33.3%)
had extracanalicular tumor of approximately 30 mm. The
other two patients had intracanalicular tumors.
Identification of those patients with SHL that resulted
from VS still remains a major clinical challenge. Unfortunately,
there are no pathognomonic signs of SHL caused by VS.
There are no clinical evidences that allow us to safely tell
which SHL cases are resulting from VS from those that are
not. In epidemiological terms, the younger the patient is,
the higher the likelihood of it being consequence of VS13.
Sudden Hearing Loss due to VS also tends to be milder than
those caused by other causes (viral, CVA, fistulas, acute
labyrinthitis and head trauma)13. The improvement of SHL,
with or without treatment, does not exclude VS diagnosis.
The improvement of Sudden Hearing Loss caused by VS is
reported as rare 12,14, but partial to total improvement may
occur with steroid therapy 1,4,12,14-17. Steroid drugs may act
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on the edema and ischemia resulting from inflammation,
leading to the reduction of the intracanalicular tumor mass
through absorption of intratumor fluids. 1In this case study
two (66.6%) out of three patients developed Sudden Hearing
Loss due to VS and achieved partial to complete
improvement with steroid therapy.
There are not many fully reliable methods for
diagnostic exclusion of VS. Conventional VS audiometry
demonstrated mild to moderate loss with low level of
discrimination. Several studies however do not show
conventional audiometric pattern1,12,14,18. Owing to several
likely etiopathogenic mechanisms VS may cause SHL of
varied intensity, both cochlear and retrocochlear losses, in
high, medium and low frequencies, with or without stapedian
reflex. Therefore, it is very difficult to differentiate through
audiometry patients with Vestibular Schwannomas among
those with SHL.
Audiometry brainstem response audiometry (ABR) is
viewed as the most sensitive and reliable electrophysiological
exam for diagnosis of VS, with 5% or less false-negative
rates19,20. Chaimoff (1999), however, found 15% false-
negative rate, making it unfeasible to use this exam as
screening method to exclude VS in SHL. 13
The exam of choice for VS diagnosis is MRI1,13,21. It is
the most sensitive and specific exam for diagnosis of VS,
therefore MRI is recommended for all patients with SHL to
obtain better etiological analysis ,13,21,22. Case 1 is a good
example of the impossibility of excluding the presence of
VS with conventional investigation methods, placing MRI as
the required exam for diagnostic investigation of SHL.
The rate of VS in cases of SHL found in literature was
1% 6. In our practice, upon performance of MRI in all patients
with SHL the incidence found was 6.1%. We believe such
higher rate found in this study was due to MRI tests
performed in all patients, including those with improved
symptoms, since this fact does not exclude the presence of
VS1. MRI is not applied as a routine exam of patients with
audiovestibular symptoms due to its high cost, but Schick
(2001) recommended MRI limited to IAC and
cerebellopontine angle as screening method in patients with
vestibular cochlear symptoms. 21,22.
The current literature corroborates the results found
in this study 23. Nageris & Popovtzer (2003) investigated 67
patients with SHL using MRI and found VS in 36% of the
cases23. In our opinion, this incidence could be overestimated,
due to some factors. Firstly, Nageris & Popovtzer considered
SHL as sensorineural losses of only 10 dB in 2 contiguous
frequencies, whereas we used the minimum limit of 30 dB
in at least 3 contiguous frequencies. Still, a defined limit of
days for the onset of the disease was not set in his study as
it was in the present study (3 days). It leads to inclusion of
milder cases of hearing loss, not always of sudden onset,
with likely increase of VS incidence. The authors mentioned
middle or external ear diseases, endolymphatic hydropsia,
perilymphatic fistula and systemic diseases as exclusion
criteria. The exclusion of such patients also increased VS
incidence in their cases, leading to overestimated results.
Regardless of such overestimation, the results also showed
that probably the actual incidence of VS is higher than the
1% classically rated and described in literature. It also shows
the importance of MRI for the diagnosis of VS in patients
with SHL.
Assuming that the current incidence of VS in SHL is
higher than that conventionally described, and considering
that MRI is the only reliable exam for exclusion diagnosis of
VS, the authors of the present study recommend the
performance of MRI in all patients with SHL, since its high
cost would be justified by the increased frequency of VS
cases diagnosed.
CONCLUSION
The incidence of Vestibular Schwannomas in the
sample of Sudden Hearing Loss is higher than that described
in literature. Such discrepancy is related to underdiagnosis
and lack of routine use of MRI in such cases. In the opinion
of the authors of the present study, MRI should be carried
out in all patients with Sudden Hearing Loss.
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